Related Experiment Video
Updated: Aug 18, 2025

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S.
Connor Willis1, Hillevi Bauer1, Trang H Au1
1Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Oncotarget
|December 6, 2022
Abstract
No abstract available in PubMed .
Related Concept Videos
Cancer Survival Analysis
413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Comparing the Survival Analysis of Two or More Groups
247
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
247

